4 Results for "

SARS 3CLpro-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SARS 3CLpro-IN-2" in MCE Product Catalog:

Cat. No.: HY-160594
CAS No.: 890648-80-3
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS 3CLpro-IN-2 (Example 9) is a severe acute respiratory syndrome 3C-like protease (SARS 3CL pro) inhibitor with an IC50 of 0.02 mM. It exhibits antiviral activity against SARS with an EC50 of 42 mM. SARS 3CLpro-IN-2 can be used in research related to severe acute respiratory syndrome .
loading...
    loading...
Cat. No.: HY-146998
CAS No.: 2765088-93-3
Purity:  99.71%
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases .
loading...
    loading...
Cat. No.: HY-W760546
CAS No.: 3156-41-0
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-15 (compound a) is a beta-nitrostyrene coronavirus SARS-CoV-2 inhibitor that targets the SARS-CoV-2 3CL protease (3CLpro). SARS-CoV-2 3CLpro-IN-15 inhibits viral replication and transcription and plays a key role in the discovery of anti-COVID-19 lead compounds .
loading...
    loading...
Cat. No.: HY-184269
Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-38 is a 3CLpro inhibitor with an IC50 of 0.34 μM against SARS-CoV-2 3CLpro and an IC50 of 0.12 μM against MERS-CoV 3CLpro. SARS-CoV-2 3CLpro-IN-38 inhibits recombinant Cathepsin L with an IC50 of 5.23 nM. SARS-CoV-2 3CLpro-IN-38 inhibits cysteine proteases essential for the replication of SARS-CoV-2 and MERS-CoV, suppresses host cysteine proteases involved in coronavirus entry, blocks viral entry, and inhibits viral replication. SARS-CoV-2 3CLpro-IN-38 can be used in the research of COVID-19 .
loading...
    loading...